DIAMINESQSpecialty Chemicals
Diamines and Chemicals Ltd — Cash Flow Statement
₹233.31
+5.22%
Diamines and Chemicals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -9.04 Cr | 13.29 Cr | -7.01 Cr | 12.30 Cr | — |
| Issuance Of Debt | 0.03 Cr | 0.00 | — | — | — |
| Issuance Of Capital Stock | 0.00 | 8000.00 | 0.00 | — | — |
| Capital Expenditure | -4.01 Cr | -8.61 Cr | -23.29 Cr | -14.97 Cr | — |
| End Cash Position | 21.92 Cr | 2.54 Cr | 2.61 Cr | 1.00 Cr | — |
| Beginning Cash Position | 2.54 Cr | 2.61 Cr | 1.00 Cr | 0.50 Cr | — |
| Changes In Cash | 19.38 Cr | -0.07 Cr | 1.61 Cr | 0.50 Cr | — |
| Financing Cash Flow | 9.75 Cr | -3.13 Cr | -6.01 Cr | -5.28 Cr | — |
| Net Other Financing Charges | 12.51 Cr | — | -30100.00 | — | — |
| Interest Paid Cff | -0.34 Cr | -0.20 Cr | -0.14 Cr | -0.09 Cr | — |
| Cash Dividends Paid | -2.45 Cr | -2.94 Cr | -5.87 Cr | -4.89 Cr | — |
| Common Stock Dividend Paid | -2.45 Cr | -2.94 Cr | -5.87 Cr | -4.89 Cr | — |
| Net Common Stock Issuance | 0.00 | 8000.00 | 0.00 | — | — |
| Common Stock Issuance | 0.00 | 8000.00 | 0.00 | — | — |
| Net Issuance Payments Of Debt | 0.03 Cr | 0.00 | 0.00 | -0.30 Cr | — |
| Net Long Term Debt Issuance | 0.03 Cr | 0.00 | — | — | — |
| Long Term Debt Issuance | 0.03 Cr | 0.00 | — | — | — |
| Investing Cash Flow | 14.65 Cr | -18.83 Cr | -8.66 Cr | -21.49 Cr | — |
| Net Other Investing Changes | 0.01 Cr | — | 15.09 Cr | -7.36 Cr | -5.38 Cr |
| Interest Received Cfi | 2.20 Cr | 2.16 Cr | 2.06 Cr | 1.63 Cr | — |
| Dividends Received Cfi | 0.16 Cr | 0.23 Cr | 0.16 Cr | 0.08 Cr | — |
| Net Investment Purchase And Sale | 16.23 Cr | -12.72 Cr | 15.09 Cr | -7.36 Cr | — |
| Sale Of Investment | 16.23 Cr | 0.00 | 15.18 Cr | 0.14 Cr | — |
| Purchase Of Investment | 0.00 | -12.72 Cr | -2.77 Cr | -3.25 Cr | — |
| Net PPE Purchase And Sale | -3.95 Cr | -8.50 Cr | -23.29 Cr | -12.73 Cr | — |
| Sale Of PPE | 0.07 Cr | 0.11 Cr | 17000.00 | 2.24 Cr | — |
| Purchase Of PPE | -4.01 Cr | -8.61 Cr | -23.29 Cr | -14.97 Cr | — |
| Operating Cash Flow | -5.02 Cr | 21.90 Cr | 16.28 Cr | 27.27 Cr | — |
| Taxes Refund Paid | -0.91 Cr | -6.56 Cr | -14.64 Cr | -6.21 Cr | — |
| Change In Working Capital | -12.10 Cr | 4.57 Cr | -25.13 Cr | 10.53 Cr | — |
| Change In Other Current Liabilities | -1.78 Cr | -0.21 Cr | 1.13 Cr | 1.39 Cr | — |
| Change In Other Current Assets | -0.10 Cr | -0.34 Cr | -0.45 Cr | 0.26 Cr | — |
| Change In Payable | 3.61 Cr | -2.48 Cr | 5.27 Cr | -0.48 Cr | — |
| Change In Inventory | -14.32 Cr | -0.52 Cr | -14.53 Cr | 10.24 Cr | — |
| Change In Receivables | 0.49 Cr | 8.12 Cr | -16.56 Cr | -0.88 Cr | — |
| Other Non Cash Items | -2.30 Cr | -1.90 Cr | -1.91 Cr | -1.54 Cr | — |
| Stock Based Compensation | 0.11 Cr | — | — | — | — |
| Provisionand Write Offof Assets | 2.05 Cr | -0.02 Cr | -18000.00 | -0.08 Cr | — |
| Depreciation And Amortization | 3.49 Cr | 2.85 Cr | 1.78 Cr | 1.67 Cr | — |
| Depreciation | 3.49 Cr | 2.85 Cr | 1.77 Cr | 1.65 Cr | — |
| Gain Loss On Investment Securities | -0.16 Cr | -0.23 Cr | -0.16 Cr | 0.52 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -45000.00 | 0.11 Cr | -0.10 Cr | -11000.00 | — |
| Gain Loss On Sale Of PPE | 0.03 Cr | -0.09 Cr | 0.10 Cr | 0.03 Cr | — |
| Net Income From Continuing Operations | 4.56 Cr | 21.77 Cr | 56.35 Cr | 22.10 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | 100.00 | — | 1000.00 |
| Net Short Term Debt Issuance | — | 0.00 | 0.00 | -0.30 Cr | 0.30 Cr |
| Net Business Purchase And Sale | — | -1.75 Cr | -2.68 Cr | -3.11 Cr | -0.74 Cr |
| Sale Of Business | — | 0.00 | 0.09 Cr | 0.14 Cr | 1.00 Cr |
| Purchase Of Business | — | -1.75 Cr | -2.77 Cr | -3.25 Cr | -1.75 Cr |
| Amortization Cash Flow | — | 0.02 Cr | 0.02 Cr | 0.02 Cr | 0.01 Cr |
| Gain Loss On Sale Of Business | — | — | — | 0.60 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Diamines and Chemicals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.